Posts Tagged ‘NIH’

NIH seeks public comment on draft clinical trial protocol template

In an effort to make it easier for investigators to prepare protocols that are consistently organized and contain all the information necessary for the clinical trial to be properly reviewed, the NIH and FDA are developing a template with instructional and sample text for NIH-funded investigators to use in writing protocols for phase 2 or 3 clinical trials that require applications for Investigational New Drugs (INDs) or Investigational Device Exemptions (IDEs). They would like you to weigh … Read More

Reminder: New NIH application requirements workshop, Mar. 9

Over the past few months, we’ve been reporting on changes to NIH grant application guidelines, many of which are meant to enhance rigor, transparency, and reproducibility of NIH-funded research. For those of you who are still uncertain about how to address rigor in your NIH applications, Research Funding and Development Services will be holding a workshop to review the new guidelines and answer any questions you may have: Wednesday, Mar. 9 1:30 to 2:30 p.m. Mackenzie … Read More

High-End Instrumentation Grant internal applications due Mar. 18

The Shared Instrument Grant Program (S10), which provides groups of NIH-supported investigators funds to purchase or upgrade shared equipment costing up to $600,000) was announced in late January.  A new S10 opportunity will open for applications on April 16, 2016. The High-End Instrumentation (HEI) Grant Program is specifically designed to fund instrumentation that costs at least $600,000. The maximum award is $2,000,000. Types of instruments supported include, but are not limited to, X-ray diffraction systems, nuclear … Read More

New vs. renewal applications: Which are more likely to be funded?

With NIH’s interest in supporting junior scientists trying to get their first grants, other investigators are wondering if it’s more difficult to get their grants renewed than to get one in the first place. The NIH looked into the matter by gathering data on R01-equivalent success rates for new and experienced investigators seeking funding in FY 2013 through 2015.  In his most recent Open Mike blog post, Deputy Director for Extramural Research Michael Lauer reported … Read More

Clarifications on new NIH requirement to consider sex as a biological variable

This past summer, we reported on a new NIH policy that goes into effect Jan. 25, 2016, requiring a deliberate approach to the consideration of sex as a biological variable (SAVB) in pre-clinical research. In a Dec. 11 Open Mike blog post, Deputy Director for Extramural Research Michael Lauer, Ph.D., clarified the application and review process and provided additional information on the origins of the policy. A current high-priority focus at NIH is improved rigor and transparency in federally … Read More

NIH up for budget increase, releases strategic plan

NIH to receive $2 billion budget increase A massive federal spending bill released on Dec. 16 provides the National Institutes of Health with a $2 billion funding increase, the agency’s first raise in more than 12 years. The bill was passed on Dec. 18. The bill provides the following for medical and healthcare-related research: $200 million to the Obama administration’s Precision Medicine Initiative $350 million increase for Alzheimer’s disease research $85 million increase for the BRAIN Initiative … Read More

NIH health economics research funding priorities defined

Health economics is used to promote health through the study of health care and health-related services, their costs and benefits, and how they are distributed among individuals and groups in society. This broad field has multiple lines of inquiry with various federal agencies providing research funding based on institutional priorities. In addition, demand for healthcare economics research continues to grow alongside rising costs and disparities. Perhaps in response to these factors, the NIH recently issued a … Read More

NIH requests for information: Optimizing NHLBI trials and improving diversity in the physician scientist workforce

1) The National Heart, Lung, and Blood Institute (NHLBI) is seeking input from the clinical trials community on how to optimize the trials NHLBI supports and administers. Of particular interest are performance milestones and metrics for selection, design, planning, conduct, and management of clinical trials including timely reporting of results to enhance scientific and public health impact. Critical elements identified by the community can then be addressed in Funding Opportunity Announcements to help guide investigators … Read More

NIH update on Precision Medicine Initiative Cohort Program

NIH Director, Francis Collins, released a statement on November 17, 2015 about progress made toward establishing a national research cohort that will be involved in  implementing the President’s Precision Medicine Initiative (PMI). The cohort will consist of roughly one million volunteers from all walks of life who will share genetic data, biological samples and diet/lifestyle information to lay the scientific foundation for precision medicine. According to Collins, the following has already been accomplished since mid-September of this year: The … Read More

OBSSR seeks input for FY 2016-2020 strategic plan

The NIH’s Office of Behavioral and Social Sciences Research (OBSSR) is in the process of establishing core scientific and policy priorities for their five year strategic plan. Because behavioral and social sciences (BSSR) research is broad in scope, and has seen rapid changes, emerging questions and concerns have come to light and they are seeking input on how to most effectively address these challenges. Input can comprise the current state of social and behavioral science which covers a … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.